BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26093874)

  • 1. Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: A population-based study.
    Cressman AM; Macdonald EM; Yao Z; Austin PC; Gomes T; Paterson JM; Kapral MK; Mamdani MM; Juurlink DN;
    Am Heart J; 2015 Jul; 170(1):133-40, 140.e1-3. PubMed ID: 26093874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M; Siu K; Francis K; Yu C; Alvrtsyan H; Rao Y; Walker D; Sander S; Miyasato G; Matchar D; Sanchez H
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):567-74. PubMed ID: 23922182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
    Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
    Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Clementy N; Haguenoer K; Fauchier L; Lip GY
    Am J Med; 2014 Oct; 127(10):972-8. PubMed ID: 24929021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin.
    Schauer DP; Moomaw CJ; Wess M; Webb T; Eckman MH
    J Gen Intern Med; 2005 Dec; 20(12):1114-9. PubMed ID: 16423100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.
    Fang MC; Go AS; Hylek EM; Chang Y; Henault LE; Jensvold NG; Singer DE
    J Am Geriatr Soc; 2006 Aug; 54(8):1231-6. PubMed ID: 16913990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.
    Wallentin L; Lopes RD; Hanna M; Thomas L; Hellkamp A; Nepal S; Hylek EM; Al-Khatib SM; Alexander JH; Alings M; Amerena J; Ansell J; Aylward P; Bartunek J; Commerford P; De Caterina R; Erol C; Harjola VP; Held C; Horowitz JD; Huber K; Husted S; Keltai M; Lanas F; Lisheng L; McMurray JJ; Oh BH; Rosenqvist M; Ruzyllo W; Steg PG; Vinereanu D; Xavier D; Granger CB;
    Circulation; 2013 Jun; 127(22):2166-76. PubMed ID: 23640971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
    Hijazi Z; Siegbahn A; Andersson U; Granger CB; Alexander JH; Atar D; Gersh BJ; Mohan P; Harjola VP; Horowitz J; Husted S; Hylek EM; Lopes RD; McMurray JJ; Wallentin L;
    Circulation; 2014 Feb; 129(6):625-34. PubMed ID: 24226808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
    Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
    Thromb Haemost; 2009 May; 101(5):938-42. PubMed ID: 19404548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system.
    Darkow T; Vanderplas AM; Lew KH; Kim J; Hauch O
    Curr Med Res Opin; 2005 Oct; 21(10):1583-94. PubMed ID: 16238898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Death and disability from warfarin-associated intracranial and extracranial hemorrhages.
    Fang MC; Go AS; Chang Y; Hylek EM; Henault LE; Jensvold NG; Singer DE
    Am J Med; 2007 Aug; 120(8):700-5. PubMed ID: 17679129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs.
    Garcia DA; Lopes RD; Hylek EM
    Thromb Haemost; 2010 Dec; 104(6):1099-105. PubMed ID: 20886196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
    Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
    Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study.
    Vestergaard AS; Skjøth F; Lip GY; Larsen TB
    Stroke; 2016 Apr; 47(4):979-85. PubMed ID: 26883499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
    Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalization for hemorrhage among warfarin recipients prescribed amiodarone.
    Lam J; Gomes T; Juurlink DN; Mamdani MM; Pullenayegum EM; Kearon C; Spencer FA; Paterson M; Zheng H; Holbrook AM
    Am J Cardiol; 2013 Aug; 112(3):420-3. PubMed ID: 23664078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin use and stroke risk among patients with nonvalvular atrial fibrillation in a large managed care population.
    Deitelzweig SB; Buysman E; Pinsky B; Lacey M; Jing Y; Wiederkehr D; Graham J
    Clin Ther; 2013 Aug; 35(8):1201-10. PubMed ID: 23867114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.